Medprin Regenerative Medical Technologies Co Ltd Class A 301033
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥42.49
- Day Range
- ¥42.60–48.46
- 52-Week Range
- ¥22.37–48.46
- Bid/Ask
- ¥47.77 / ¥47.78
- Market Cap
- ¥3.16 Bil
- Volume/Avg
- 1.6 Mil / 557,526
Key Statistics
- Price/Earnings (Normalized)
- 56.87
- Price/Sales
- 11.79
- Dividend Yield (Trailing)
- 0.84%
- Dividend Yield (Forward)
- 0.84%
- Total Yield
- 0.84%
Company Profile
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 278
- Website
- https://www.medprin.com
Comparables
Valuation
Metric
|
301033
|
688161
|
688212
|
---|---|---|---|
Price/Earnings (Normalized) | 56.87 | 101.26 | 90.33 |
Price/Book Value | 4.95 | 2.91 | 4.71 |
Price/Sales | 11.79 | 9.32 | 9.20 |
Price/Cash Flow | 33.90 | 69.09 | 37.48 |
Price/Earnings
301033
688161
688212
Financial Strength
Metric
|
301033
|
688161
|
688212
|
---|---|---|---|
Quick Ratio | 4.60 | 2.16 | 4.28 |
Current Ratio | 6.54 | 4.05 | 6.04 |
Interest Coverage | 40.89 | 91.82 | 22.43 |
Quick Ratio
301033
688161
688212
Profitability
Metric
|
301033
|
688161
|
688212
|
---|---|---|---|
Return on Assets (Normalized) | 7.51% | 1.75% | 0.62% |
Return on Equity (Normalized) | 8.88% | 2.31% | 0.72% |
Return on Invested Capital (Normalized) | 8.37% | 1.76% | 0.61% |
Return on Assets
301033
688161
688212
Medical Devices Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Abbott Laboratories
ABT
| Lfybxvlcy | Vsbzz | $195.3 Bil | |||
Stryker Corp
SYK
| Pcdqsfkv | Qcfl | $134.0 Bil | |||
Boston Scientific Corp
BSX
| Mgtxplyb | Nfjcgd | $123.4 Bil | |||
Medtronic PLC
MDT
| Lhqjhzgr | Nlrtxt | $112.6 Bil | |||
Edwards Lifesciences Corp
EW
| Xblygblcl | Dmzyyq | $39.4 Bil | |||
Koninklijke Philips NV ADR
PHG
| Mxbk | Lyxf | $30.1 Bil | |||
DexCom Inc
DXCM
| Pfktgmltv | Dkklk | $26.3 Bil | |||
Steris PLC
STE
| Nbqlhhqf | Dhfjgq | $23.0 Bil | |||
Zimmer Biomet Holdings Inc
ZBH
| Gzpkrscrx | Qwn | $21.2 Bil | |||
Insulet Corp
PODD
| Tydlspxbv | Kppnjs | $16.1 Bil |